Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada.
Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, BC, Canada.
BJOG. 2020 Sep;127(10):1189-1198. doi: 10.1111/1471-0528.16225. Epub 2020 Apr 13.
We assessed the incidence, risk factors and adverse birth outcomes associated with elevated liver enzymes and low platelets (HELLP) syndrome.
A retrospective population-based cohort study.
Canada (excluding Quebec), 2012/2013-2015/2016.
Mothers with a singleton hospital live birth or stillbirth at ≥24 weeks' gestation (n = 1 078 323).
HELLP syndrome was identified using ICD-10-CA diagnostic code from delivery hospitalisation data. We used logistic regression to identify independent risk factors for HELLP syndrome by obtaining adjusted odds ratios (AOR) and 95% confidence intervals (CI), and to assess the associations with adverse outcomes.
Adverse maternal (e.g. eclampsia) and fetal/neonatal outcomes (e.g. intraventricular haemorrhage, perinatal death).
The incidence of HELLP syndrome was 2.5 per 1000 singleton deliveries (n = 2663). Risk factors included: age ≥35 years, rural residence, nulliparity, parity ≥4, pre-pregnancy and gestational hypertension and diabetes, assisted reproduction, chronic cardiac conditions, systemic lupus erythematosus, obesity, chronic hepatic conditions, placental disorders (e.g. fetomaternal transfusion) and congenital anomalies. PROM and age <25 years were inversely associated with HELLP syndrome (P-values <0.05). Women with the syndrome had a 10-fold higher maternal mortality (95% CI 1.6-84.3) and elevated severe maternal morbidity (9.6 versus 121.7 per 1000; AOR 12.5, 95% CI 11.1-14.1); and higher perinatal mortality (4.3 versus 21.0 per 1000; AOR 4.5, 95% CI 3.5-5.9) and perinatal mortality/severe neonatal morbidity (21.2 versus 202.4 per 1000; AOR 10.7, 95% CI 9.7-11.8).
HELLP syndrome is associated with specific pre-pregnancy and pregnancy risk factors, higher rates of maternal death, and substantially higher severe maternal morbidity, perinatal mortality and severe neonatal morbidity.
HELLP syndrome is associated with higher maternal death rate, and substantially higher severe maternal and neonatal morbidity, and perinatal mortality.
评估与肝酶升高和血小板减少(HELLP)综合征相关的发病率、风险因素和不良母婴结局。
回顾性基于人群的队列研究。
加拿大(魁北克除外),2012/2013 年至 2015/2016 年。
≥24 周妊娠的单胎活产或死胎产妇(n=1078323)。
通过分娩住院数据中的 ICD-10-CA 诊断代码确定 HELLP 综合征。我们使用逻辑回归确定 HELLP 综合征的独立风险因素,获得调整后的优势比(AOR)和 95%置信区间(CI),并评估与不良结局的关联。
不良母体结局(如子痫)和胎儿/新生儿结局(如脑室出血、围产儿死亡)。
HELLP 综合征的发病率为每 1000 例活产 2.5 例(n=2663)。风险因素包括:年龄≥35 岁、农村居住、初产妇、产次≥4、孕前和妊娠期高血压和糖尿病、辅助生殖、慢性心脏疾病、系统性红斑狼疮、肥胖、慢性肝脏疾病、胎盘疾病(如胎儿-母体输血)和先天性异常。胎膜早破和年龄<25 岁与 HELLP 综合征呈负相关(P 值均<0.05)。患有该综合征的产妇的死亡率高出 10 倍(95%CI 1.6-84.3),严重母体发病率显著升高(每 1000 例 9.6 例 vs. 121.7 例;AOR 12.5,95%CI 11.1-14.1),围产儿死亡率也升高(每 1000 例 4.3 例 vs. 21.0 例;AOR 4.5,95%CI 3.5-5.9),围产儿死亡率/严重新生儿发病率升高(每 1000 例 21.2 例 vs. 202.4 例;AOR 10.7,95%CI 9.7-11.8)。
HELLP 综合征与特定的孕前和妊娠风险因素相关,产妇死亡率较高,且严重母体发病率、围产儿死亡率和严重新生儿发病率显著升高。
HELLP 综合征与较高的产妇死亡率以及严重的母体和新生儿发病率以及围产儿死亡率显著相关。